Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2025-12-30 @ 2:11 AM
Study NCT ID:
NCT04447469
Status:
COMPLETED
Last Update Posted:
2025-01-22
First Post:
2020-06-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation
Sponsor:
Kiniksa Pharmaceuticals International, plc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-23
First Submit QC Date:
None
Study First Post Date:
2020-06-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-09-21
Results First Submit QC Date:
None
Results First Post Date:
2025-01-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-01-22
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-12-27
Last Update Post Date:
2025-01-22
Last Update Post Date Type:
ACTUAL